Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 63

Proposed £50 million capital return and trading update

Published17/07/2019

Read more
Vectura Group Plc announces leadership changes

Published10/06/2019

Read more
QVM149 submission means early $2.5m payment for Vectura

Published24/05/2019

Read more
Vectura data to be shared at ATS 2019

Published15/05/2019

Read more
Vectura wins US GSK patent litigation and awarded $89.7m in damages by jury

Published26/04/2019

Read more
R&D: Transformation frees up more resources for innovation

Published10/04/2019

Read more
Vectura reports strong 2018 financial and operational performance

Published26/03/2019

Read more
Pre-close trading update confirms good progress against 2018 goals

Published03/01/2019

Read more
Global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio

Published08/11/2018

Read more
Rising to the challenge of developing inhaled generic medicines

Published26/09/2018

Read more
Vectura Group Interim Results for H1 2018

Published11/09/2018

Read more
Fundraising for AsthmaUK

Published06/07/2018

Read more

Displaying 12 of 63